BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Michael Phelps, World Champion Athlete And Mental Health Advocate, Appointed To Medibio Board Of Directors

  June 5, 2017

   · 

  5 min read
• Drug Development

  MabVax Therapeutics Phase I Trial Results Of Antibody Therapy MVT-5873 For The Treatment Of Advanced Pancreatic Cancer Presented At The 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  7 min read
• Drug Development

  AbbVie Release: Long-Term IMBRUVICA (ibrutinib) Efficacy And Safety Data At ASCO 2017 Show Sustained Survival Rates In Up To Four Years In Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients, Including Those With

  June 5, 2017

   · 

  14 min read
• Biotech Beach

  Poseida Therapeutics Presents High-Fidelity Genome Editing System For Production Of Allogeneic “Universal Donor” CAR-T Cells At ASCO Annual Meeting

  June 5, 2017

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb Release: Early, Durable Responses Seen With Sprycel (Dasatinib) In First- And Second-Line Treatment Of Pediatric Patients With Chronic Myeloid Leukemia In Chronic Phase (CP-CML)

  June 5, 2017

   · 

  2 min read
• Drug Development

  NYU Langone Medical Center Release: Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer

  June 5, 2017

   · 

  3 min read
• Drug Development

  Seres Therapeutics Announces Completion Of Enrollment For SER-287 Phase IIb Study In Patients With Ulcerative Colitis

  June 5, 2017

   · 

  7 min read
• Drug Development

  GlycoMimetics Presents Updated Data From Ongoing Phase I/II Clinical Trial Of GMI-1271 In Patients With Acute Myeloid Leukemia At ASCO 2017 Annual Meeting

  June 5, 2017

   · 

  6 min read
• Business

  Updated Data From ECHO-202 Trial Of Incyte’s Epacadostat In Combination With Merck & Co.’s KEYTRUDA (Pembrolizumab) Demonstrate Clinical Activity Across Multiple Tumor Types

  June 5, 2017

   · 

  1 min read
• Drug Development

  Zavante Therapeutics Reports ZOLYD Broad Spectrum Activity And Synergy With Multiple Antibiotics; In Vitro Studies Presented At ASM Microbe 2017 Meeting

  June 5, 2017

   · 

  6 min read